Bentham Science Logo

Track Your Manuscript:

Current Pharmaceutical Biotechnology

Volume 23, 15 Issues, 2022
ISSN: 1873-4316 (Online)
ISSN: 1389-2010 (Print)
This journal supports open access


Current Pharmaceutical Biotechnology , Volume 13 - Number 11

Current Status of Therapeutic Targeting of Developmental Signalling Pathways in Oncology

, 13(11): 2184 - 2220

Tobias Kiesslich, Frieder Berr, Beate Alinger, Ralf Kemmerling, Martin Pichler, Matthias Ocker and Daniel Neureiter

DOI: 10.2174/138920112802502114

Apoptosis Signalling Activated by TNF in the Lower Gastrointestinal Tract-Review

, 13(11): 2248 - 2258

Natalya Benderska, Saritha Chakilam, Manuela Hugle, Jelena Ivanovska, Muktheshwar Gandesiri, Jan Schulze-Luhrmann, Khuloud Bajbouj, Ronald Croner and Regine Schneider-Stock

DOI: 10.2174/138920112802501971

Combination of Hypoxia and RNA-Interference Targeting VEGF Induces Apoptosis in Hepatoma Cells Via Autocrine Mechanisms

, 13(11): 2290 - 2298

Esther Raskopf, Annabelle Vogt, Georges Decker, Sarah Hirt, Katjana Daskalow, Thorsten Cramer, Jens Standop, Maria-Angeles Gonzalez-Carmona, Tilman Sauerbruch and Volker Schmitz

DOI: 10.2174/138920112802502088


Nikolaos Labrou
School of Food, Biotechnology and Development
Department of Biotechnology
Agricultural University of Athens
View Full Editorial Board

COPE Compliant

Cope Logo

Journal History

Current Pharmaceutical Biotechnology was launched in 2000. Dr. Nikolaos Labrou serves as the Editor-in-Chief of the journal.

Related Journals

Related eBooks

eBooks Catalog